Compugen

$12.33
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.13 (+1.07%) Today
$0.00 (0.00%) As of 8:00 PM EST after-hours

Why Robinhood?

You can buy or sell Compugen and other stocks, options, and ETFs commission-free!

About CGEN

Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. The listed name for CGEN is Compugen Ltd. Ordinary Shares.

CEO
Anat Cohen-Dayag
Employees
61
Headquarters
Holon, Tel Aviv
Founded
1993
Market Cap
1.02B
Price-Earnings Ratio
Dividend Yield
Average Volume
883.37K
High Today
$12.88
Low Today
$12.27
Open Price
$12.43
Volume
1.01M
52 Week High
$19.90
52 Week Low
$5.20

Collections

CGEN Earnings

-$0.17
-$0.11
-$0.06
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Feb 18, Pre-Market

You May Also Like